Verified Nov 2026
Batteries & E-Mobility
·
Cambridge, Massachusetts
·
Since 1989
Vericel Corporation is a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, United States. Founded in 1989, it is publicly listed under the ticker VCEL and employs between 200 and 500 people. The company develops, manufactures, and commercializes cell therapies and specialty biologics for sports medicine and severe burn care. Its MACI autologous cell therapy for knee cartilage repair is its principal product, and in April 2026 it announced a BARDA award valued at up to $197 million for procurement and advanced development of its NexoBrid product.
Vericel® Corporation at a glance
Revenue
276.3M
Employees
200-500
Founded
1989
Headquarters
Cambridge, Massachusetts
Ownership
Publicly traded (NASDAQ: VCEL)
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Vericel Corporation is a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, United States. Founded in 1989, it is publicly listed under the ticker VCEL and employs between 200 and 500 people. The company develops, manufactures, and commercializes cell therapies and specialty biologics for sports medicine and severe burn care. Its MACI autologous cell therapy for knee cartilage repair is its principal product, and in April 2026 it announced a BARDA award valued at up to $197 million for procurement and advanced development of its NexoBrid product.
At a glance
Attribute | Detail |
|---|---|
Founded | 1989 |
Headquarters | Cambridge, Massachusetts |
Employees | 200-500 |
Revenue | 276.3M |
Ownership | Publicly traded (NASDAQ: VCEL) |
Primary capability | Batteries & E-Mobility |
What Vericel® Corporation makes
The company's portfolio includes MACI for knee cartilage repair, Epicel as a permanent skin replacement for severe burns, and NexoBrid for removing dead tissue in burn patients, with manufacturing facilities in the United States.
Latest developments
2026-11-05 — Vericel Reports Third Quarter 2026 Financial Results and (globenewswire.com)
2026-11-05 — Vericel Corp (VCEL) Q3 2026 Earnings Call Transcript | The Motley Fool (fool.com)
2026-05-07 — Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance | Vericel Corporation (vcel.com)
2026-04-02 — Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid | Vericel Corporation (vcel.com)
2026-04-02 — MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million | MediWound (mediwound.com)
2026-03-04 — Vericel Announces FDA Approval of New State-of-the-Art Advanced Therapy Manufacturing Facility | Vericel Corporation (vcel.com)
Facilities
Vericel® Corporation is headquartered in Cambridge, Massachusetts. Public sources also reference these locations:
Burlington, Massachusetts — vcel.com
Company details
Vericel reported approximately $238.6 million in revenue for fiscal year 2024, driven primarily by MACI, and works with orthopedic and burn surgeons to deliver its therapies. Vericel® Corporation was founded in 1989, has an estimated 200-500 employees, and is headquartered in Cambridge, Massachusetts.
Frequently asked questions
What does Vericel® Corporation make?
Vericel Corporation is a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, United States. Founded in 1989, it is publicly listed under the ticker VCEL and employs between 200 and 500 people. The company develops, manufactures, and commercializes cell therapies and specialty biologics for sports medicine and severe burn care. Its MACI autologous cell therapy for knee cartilage repair is its principal product, and in April 2026 it announced a BARDA award valued at up to $197 million for procurement and advanced development of its NexoBrid product.
Where is Vericel® Corporation headquartered?
Vericel® Corporation is headquartered in Cambridge, Massachusetts (64 Sidney St, Cambridge, Massachusetts, 02139).
When was Vericel® Corporation founded?
Vericel® Corporation was founded in 1989.
How big is Vericel® Corporation?
Vericel® Corporation has an estimated 200-500 employees, with revenue in the 276.3M range.
Is Vericel® Corporation publicly traded?
Publicly traded (NASDAQ: VCEL). Public financial figures are drawn from its filings.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.